Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs179008

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chrX:12885540 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
A>C / A>T
Variation Type
SNV Single Nucleotide Variation
Frequency
T=0.177022 (46856/264690, TOPMED)
T=0.177701 (31777/178823, GnomAD_exome)
T=0.185659 (19232/103588, GnomAD) (+ 14 more)
T=0.19978 (18561/92906, ALFA)
T=0.18008 (15217/84503, ExAC)
T=0.18461 (1950/10563, GO-ESP)
T=0.1193 (573/4805, 1000G_30x)
T=0.1181 (446/3775, 1000G)
T=0.2174 (806/3708, TWINSUK)
T=0.2070 (598/2889, ALSPAC)
T=0.236 (126/534, MGP)
T=0.131 (43/328, HapMap)
T=0.093 (10/108, Qatari)
A=0.33 (23/70, SGDP_PRJ)
T=0.00 (0/48, Vietnamese)
T=0.28 (11/40, GENOME_DK)
A=0.25 (3/12, Siberian)
Clinical Significance
Not Reported in ClinVar
Gene : Consequence
TLR7 : Missense Variant
Publications
51 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 92906 A=0.80022 T=0.19978 0.714959 0.114524 0.170516 32
European Sub 79870 A=0.78606 T=0.21394 0.695004 0.122875 0.182121 32
African Sub 4302 A=0.8629 T=0.1371 0.796839 0.07113 0.132032 32
African Others Sub 174 A=0.851 T=0.149 0.793103 0.091954 0.114943 14
African American Sub 4128 A=0.8634 T=0.1366 0.796996 0.070252 0.132752 32
Asian Sub 3326 A=1.0000 T=0.0000 1.0 0.0 0.0 N/A
East Asian Sub 2672 A=1.0000 T=0.0000 1.0 0.0 0.0 N/A
Other Asian Sub 654 A=1.000 T=0.000 1.0 0.0 0.0 N/A
Latin American 1 Sub 436 A=0.828 T=0.172 0.752294 0.09633 0.151376 26
Latin American 2 Sub 928 A=0.816 T=0.184 0.724138 0.092672 0.18319 32
South Asian Sub 274 A=0.938 T=0.062 0.912409 0.036496 0.051095 23
Other Sub 3770 A=0.8353 T=0.1647 0.771883 0.101326 0.12679 32


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 A=0.822978 T=0.177022
gnomAD - Exomes Global Study-wide 178823 A=0.822299 T=0.177701
gnomAD - Exomes European Sub 95773 A=0.77459 T=0.22541
gnomAD - Exomes Asian Sub 31567 A=0.95679 T=0.04321
gnomAD - Exomes American Sub 26837 A=0.81101 T=0.18899
gnomAD - Exomes African Sub 13108 A=0.87115 T=0.12885
gnomAD - Exomes Ashkenazi Jewish Sub 7116 A=0.8294 T=0.1706
gnomAD - Exomes Other Sub 4422 A=0.8078 T=0.1922
gnomAD - Genomes Global Study-wide 103588 A=0.814341 T=0.185659
gnomAD - Genomes European Sub 56756 A=0.77854 T=0.22146
gnomAD - Genomes African Sub 31243 A=0.87159 T=0.12841
gnomAD - Genomes American Sub 9270 A=0.7900 T=0.2100
gnomAD - Genomes Ashkenazi Jewish Sub 2513 A=0.8317 T=0.1683
gnomAD - Genomes East Asian Sub 2234 A=0.9996 T=0.0004
gnomAD - Genomes Other Sub 1572 A=0.8219 T=0.1781
Allele Frequency Aggregator Total Global 92906 A=0.80022 T=0.19978
Allele Frequency Aggregator European Sub 79870 A=0.78606 T=0.21394
Allele Frequency Aggregator African Sub 4302 A=0.8629 T=0.1371
Allele Frequency Aggregator Other Sub 3770 A=0.8353 T=0.1647
Allele Frequency Aggregator Asian Sub 3326 A=1.0000 T=0.0000
Allele Frequency Aggregator Latin American 2 Sub 928 A=0.816 T=0.184
Allele Frequency Aggregator Latin American 1 Sub 436 A=0.828 T=0.172
Allele Frequency Aggregator South Asian Sub 274 A=0.938 T=0.062
ExAC Global Study-wide 84503 A=0.81992 T=0.18008
ExAC Europe Sub 51865 A=0.77598 T=0.22402
ExAC Asian Sub 14324 A=0.95113 T=0.04887
ExAC American Sub 9277 A=0.8218 T=0.1782
ExAC African Sub 8430 A=0.8671 T=0.1329
ExAC Other Sub 607 A=0.794 T=0.206
GO Exome Sequencing Project Global Study-wide 10563 A=0.81539 T=0.18461
GO Exome Sequencing Project European American Sub 6728 A=0.7876 T=0.2124
GO Exome Sequencing Project African American Sub 3835 A=0.8641 T=0.1359
1000Genomes_30x Global Study-wide 4805 A=0.8807 T=0.1193
1000Genomes_30x African Sub 1328 A=0.8810 T=0.1190
1000Genomes_30x Europe Sub 961 A=0.779 T=0.221
1000Genomes_30x South Asian Sub 883 A=0.947 T=0.053
1000Genomes_30x East Asian Sub 878 A=1.000 T=0.000
1000Genomes_30x American Sub 755 A=0.793 T=0.207
1000Genomes Global Study-wide 3775 A=0.8819 T=0.1181
1000Genomes African Sub 1003 A=0.8804 T=0.1196
1000Genomes Europe Sub 766 A=0.769 T=0.231
1000Genomes East Asian Sub 764 A=1.000 T=0.000
1000Genomes South Asian Sub 718 A=0.947 T=0.053
1000Genomes American Sub 524 A=0.788 T=0.212
UK 10K study - Twins TWIN COHORT Study-wide 3708 A=0.7826 T=0.2174
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 2889 A=0.7930 T=0.2070
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 A=0.764 T=0.236
HapMap Global Study-wide 328 A=0.869 T=0.131
HapMap African Sub 120 A=0.808 T=0.192
HapMap American Sub 120 A=0.833 T=0.167
HapMap Asian Sub 88 A=1.00 T=0.00
Qatari Global Study-wide 108 A=0.907 T=0.093
SGDP_PRJ Global Study-wide 70 A=0.33 T=0.67
A Vietnamese Genetic Variation Database Global Study-wide 48 A=1.00 T=0.00
The Danish reference pan genome Danish Study-wide 40 A=0.72 T=0.28
Siberian Global Study-wide 12 A=0.25 T=0.75
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr X NC_000023.11:g.12885540A>C
GRCh38.p14 chr X NC_000023.11:g.12885540A>T
GRCh37.p13 chr X NC_000023.10:g.12903659A>C
GRCh37.p13 chr X NC_000023.10:g.12903659A>T
TLR7 RefSeqGene NG_012569.1:g.23458A>C
TLR7 RefSeqGene NG_012569.1:g.23458A>T
Gene: TLR7, toll like receptor 7 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
TLR7 transcript NM_016562.4:c.32A>C Q [CAA] > P [CCA] Coding Sequence Variant
toll-like receptor 7 precursor NP_057646.1:p.Gln11Pro Q (Gln) > P (Pro) Missense Variant
TLR7 transcript NM_016562.4:c.32A>T Q [CAA] > L [CTA] Coding Sequence Variant
toll-like receptor 7 precursor NP_057646.1:p.Gln11Leu Q (Gln) > L (Leu) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Not Reported in ClinVar
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement A= C T
GRCh38.p14 chr X NC_000023.11:g.12885540= NC_000023.11:g.12885540A>C NC_000023.11:g.12885540A>T
GRCh37.p13 chr X NC_000023.10:g.12903659= NC_000023.10:g.12903659A>C NC_000023.10:g.12903659A>T
TLR7 RefSeqGene NG_012569.1:g.23458= NG_012569.1:g.23458A>C NG_012569.1:g.23458A>T
TLR7 transcript NM_016562.4:c.32= NM_016562.4:c.32A>C NM_016562.4:c.32A>T
TLR7 transcript NM_016562.3:c.32= NM_016562.3:c.32A>C NM_016562.3:c.32A>T
toll-like receptor 7 precursor NP_057646.1:p.Gln11= NP_057646.1:p.Gln11Pro NP_057646.1:p.Gln11Leu
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

100 SubSNP, 17 Frequency submissions
No Submitter Submission ID Date (Build)
1 KWOK ss238057 Jul 12, 2000 (79)
2 SC_JCM ss802490 Aug 11, 2000 (85)
3 KWOK ss1270926 Oct 04, 2000 (86)
4 TSC-CSHL ss5468152 Oct 08, 2002 (108)
5 IIPGA-WEISS-MARTINEZ ss7987787 Apr 21, 2003 (114)
6 PERLEGEN ss24728067 Sep 20, 2004 (123)
7 SEQUENOM ss24803419 Sep 20, 2004 (123)
8 APPLERA_GI ss48408941 Mar 13, 2006 (126)
9 ILLUMINA ss65725849 Oct 14, 2006 (127)
10 PERLEGEN ss69258067 May 16, 2007 (127)
11 CGM_KYOTO ss76868362 Dec 06, 2007 (129)
12 SI_EXO ss76890236 Dec 06, 2007 (129)
13 HGSV ss78450611 Dec 06, 2007 (129)
14 CNG ss86353284 Mar 23, 2008 (129)
15 SEATTLESEQ ss159745134 Dec 01, 2009 (131)
16 ILLUMINA ss160461763 Dec 01, 2009 (131)
17 BUSHMAN ss204160979 Jul 04, 2010 (132)
18 1000GENOMES ss212154456 Jul 14, 2010 (132)
19 ILLUMINA ss244284906 Jul 04, 2010 (132)
20 1000GENOMES ss341317862 May 09, 2011 (134)
21 NHLBI-ESP ss342549766 May 09, 2011 (134)
22 ILLUMINA ss481062895 Sep 08, 2015 (146)
23 ILLUMINA ss482607442 May 04, 2012 (137)
24 ILLUMINA ss484344089 May 04, 2012 (137)
25 1000GENOMES ss491198033 May 04, 2012 (137)
26 GSK-GENETICS ss491282668 May 04, 2012 (137)
27 EXOME_CHIP ss491575108 May 04, 2012 (137)
28 CLINSEQ_SNP ss491948797 May 04, 2012 (137)
29 ILLUMINA ss535313640 Sep 08, 2015 (146)
30 TISHKOFF ss566771262 Apr 25, 2013 (138)
31 ILLUMINA ss779492115 Aug 21, 2014 (142)
32 ILLUMINA ss780764900 Aug 21, 2014 (142)
33 ILLUMINA ss781817590 Aug 21, 2014 (142)
34 ILLUMINA ss783444185 Aug 21, 2014 (142)
35 ILLUMINA ss834962249 Aug 21, 2014 (142)
36 JMKIDD_LAB ss1067609017 Aug 21, 2014 (142)
37 JMKIDD_LAB ss1082798935 Aug 21, 2014 (142)
38 1000GENOMES ss1553566009 Apr 01, 2015 (144)
39 EVA_GENOME_DK ss1583331423 Apr 01, 2015 (144)
40 EVA_UK10K_ALSPAC ss1640357295 Apr 01, 2015 (144)
41 EVA_UK10K_TWINSUK ss1683351328 Apr 01, 2015 (144)
42 EVA_EXAC ss1694458747 Apr 01, 2015 (144)
43 EVA_MGP ss1711577509 Apr 01, 2015 (144)
44 ILLUMINA ss1752796249 Sep 08, 2015 (146)
45 ILLUMINA ss1917716028 Feb 12, 2016 (147)
46 WEILL_CORNELL_DGM ss1939156296 Feb 12, 2016 (147)
47 ILLUMINA ss1945968366 Feb 12, 2016 (147)
48 ILLUMINA ss1958173488 Feb 12, 2016 (147)
49 GENOMED ss1971345606 Jul 19, 2016 (147)
50 ILLUMINA ss2095001507 Dec 20, 2016 (150)
51 ILLUMINA ss2095227340 Dec 20, 2016 (150)
52 USC_VALOUEV ss2158955833 Dec 20, 2016 (150)
53 HUMAN_LONGEVITY ss2315776928 Dec 20, 2016 (150)
54 ILLUMINA ss2634940288 Nov 08, 2017 (151)
55 ILLUMINA ss2635201197 Nov 08, 2017 (151)
56 GNOMAD ss2745308291 Nov 08, 2017 (151)
57 GNOMAD ss2746078039 Nov 08, 2017 (151)
58 GNOMAD ss2976627178 Nov 08, 2017 (151)
59 AFFY ss2985480937 Nov 08, 2017 (151)
60 SWEGEN ss3019651415 Nov 08, 2017 (151)
61 ILLUMINA ss3022990797 Nov 08, 2017 (151)
62 BIOINF_KMB_FNS_UNIBA ss3029009315 Nov 08, 2017 (151)
63 NARIIMMUNO_NAWAJ ss3625488197 Oct 12, 2018 (152)
64 ILLUMINA ss3630398649 Oct 12, 2018 (152)
65 ILLUMINA ss3630398650 Oct 12, 2018 (152)
66 ILLUMINA ss3632827461 Oct 12, 2018 (152)
67 ILLUMINA ss3635242480 Oct 12, 2018 (152)
68 ILLUMINA ss3636990461 Oct 12, 2018 (152)
69 ILLUMINA ss3640949962 Oct 12, 2018 (152)
70 ILLUMINA ss3645008582 Oct 12, 2018 (152)
71 OMUKHERJEE_ADBS ss3646571084 Oct 12, 2018 (152)
72 ILLUMINA ss3653548985 Oct 12, 2018 (152)
73 ILLUMINA ss3653548986 Oct 12, 2018 (152)
74 ILLUMINA ss3654247213 Oct 12, 2018 (152)
75 ILLUMINA ss3726663797 Jul 13, 2019 (153)
76 ILLUMINA ss3744597411 Jul 13, 2019 (153)
77 ILLUMINA ss3745542906 Jul 13, 2019 (153)
78 EVA ss3769931804 Jul 13, 2019 (153)
79 ILLUMINA ss3773034620 Jul 13, 2019 (153)
80 KHV_HUMAN_GENOMES ss3822782192 Jul 13, 2019 (153)
81 EVA ss3825472930 Apr 27, 2020 (154)
82 EVA ss3836097452 Apr 27, 2020 (154)
83 SGDP_PRJ ss3891025966 Apr 27, 2020 (154)
84 FSA-LAB ss3984438596 Apr 27, 2021 (155)
85 EVA ss3984763470 Apr 27, 2021 (155)
86 EVA ss3986873351 Apr 27, 2021 (155)
87 TOPMED ss5115896519 Apr 27, 2021 (155)
88 EVA ss5237055477 Apr 27, 2021 (155)
89 1000G_HIGH_COVERAGE ss5311845190 Oct 16, 2022 (156)
90 EVA ss5316072971 Oct 16, 2022 (156)
91 HUGCELL_USP ss5503590090 Oct 16, 2022 (156)
92 1000G_HIGH_COVERAGE ss5619698139 Oct 16, 2022 (156)
93 SANFORD_IMAGENETICS ss5664895373 Oct 16, 2022 (156)
94 EVA ss5800238034 Oct 16, 2022 (156)
95 EVA ss5848227991 Oct 16, 2022 (156)
96 EVA ss5848739232 Oct 16, 2022 (156)
97 EVA ss5936581206 Oct 16, 2022 (156)
98 EVA ss5977852659 Oct 16, 2022 (156)
99 EVA ss5981149170 Oct 16, 2022 (156)
100 EVA ss5981323775 Oct 16, 2022 (156)
101 1000Genomes NC_000023.10 - 12903659 Oct 12, 2018 (152)
102 1000Genomes_30x NC_000023.11 - 12885540 Oct 16, 2022 (156)
103 The Avon Longitudinal Study of Parents and Children NC_000023.10 - 12903659 Oct 12, 2018 (152)
104 ExAC NC_000023.10 - 12903659 Oct 12, 2018 (152)
105 The Danish reference pan genome NC_000023.10 - 12903659 Apr 27, 2020 (154)
106 gnomAD - Genomes NC_000023.11 - 12885540 Apr 27, 2021 (155)
107 gnomAD - Exomes NC_000023.10 - 12903659 Jul 13, 2019 (153)
108 GO Exome Sequencing Project NC_000023.10 - 12903659 Oct 12, 2018 (152)
109 HapMap NC_000023.11 - 12885540 Apr 27, 2020 (154)
110 Medical Genome Project healthy controls from Spanish population NC_000023.10 - 12903659 Apr 27, 2020 (154)
111 Qatari NC_000023.10 - 12903659 Apr 27, 2020 (154)
112 SGDP_PRJ NC_000023.10 - 12903659 Apr 27, 2020 (154)
113 Siberian NC_000023.10 - 12903659 Apr 27, 2020 (154)
114 TopMed NC_000023.11 - 12885540 Apr 27, 2021 (155)
115 UK 10K study - Twins NC_000023.10 - 12903659 Oct 12, 2018 (152)
116 A Vietnamese Genetic Variation Database NC_000023.10 - 12903659 Jul 13, 2019 (153)
117 ALFA NC_000023.11 - 12885540 Apr 27, 2021 (155)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs629938 Sep 19, 2000 (85)
rs17256060 Oct 07, 2004 (123)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss78450611 NC_000023.8:12663315:A:C NC_000023.11:12885539:A:C (self)
ss204160979, ss212154456, ss484344089, ss491282668, ss491948797, ss2095001507, ss2635201197 NC_000023.9:12813579:A:T NC_000023.11:12885539:A:T (self)
81549628, 45049207, 9955933, 9496360, 14644727, 1929733, 693269, 21198218, 43042946, 11472187, 45049207, 9940650, ss341317862, ss342549766, ss481062895, ss482607442, ss491198033, ss491575108, ss535313640, ss566771262, ss779492115, ss780764900, ss781817590, ss783444185, ss834962249, ss1067609017, ss1082798935, ss1553566009, ss1583331423, ss1640357295, ss1683351328, ss1694458747, ss1711577509, ss1752796249, ss1917716028, ss1939156296, ss1945968366, ss1958173488, ss1971345606, ss2095227340, ss2158955833, ss2634940288, ss2745308291, ss2746078039, ss2976627178, ss2985480937, ss3019651415, ss3022990797, ss3630398649, ss3630398650, ss3632827461, ss3635242480, ss3636990461, ss3640949962, ss3645008582, ss3646571084, ss3653548985, ss3653548986, ss3654247213, ss3744597411, ss3745542906, ss3769931804, ss3773034620, ss3825472930, ss3836097452, ss3891025966, ss3984438596, ss3984763470, ss3986873351, ss5316072971, ss5664895373, ss5800238034, ss5848227991, ss5848739232, ss5936581206, ss5977852659, ss5981149170, ss5981323775 NC_000023.10:12903658:A:T NC_000023.11:12885539:A:T (self)
107224074, 575517725, 3949405, 679502876, 11396626195, ss2315776928, ss3029009315, ss3625488197, ss3726663797, ss3822782192, ss5115896519, ss5237055477, ss5311845190, ss5503590090, ss5619698139 NC_000023.11:12885539:A:T NC_000023.11:12885539:A:T (self)
ss76890236 NT_011757.15:10685341:A:T NC_000023.11:12885539:A:T (self)
ss238057, ss802490, ss1270926, ss5468152, ss7987787, ss24728067, ss24803419, ss48408941, ss65725849, ss69258067, ss76868362, ss86353284, ss159745134, ss160461763, ss244284906 NT_167197.1:10785420:A:T NC_000023.11:12885539:A:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

51 citations for rs179008
PMID Title Author Year Journal
18385087 Toll-like receptor polymorphisms and age-related macular degeneration. Edwards AO et al. 2008 Investigative ophthalmology & visual science
18682521 Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Møller-Larsen S et al. 2008 Thorax
19473567 Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. Sánchez E et al. 2009 Clinical and experimental rheumatology
19505919 Toll-like receptor signaling pathway variants and prostate cancer mortality. Stark JR et al. 2009 Cancer epidemiology, biomarkers & prevention
20456414 Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus. Lenert P et al. 2010 Clinical and experimental immunology
20595247 Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients. Enevold C et al. 2010 Multiple sclerosis (Houndmills, Basingstoke, England)
20872712 Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection. Askar E et al. 2010 Journal of medical virology
21179534 Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. Coenen MJ et al. 2010 PloS one
21297422 Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1. Chang J et al. 2011 AIDS (London, England)
21872627 Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Kutikhin AG et al. 2011 Human immunology
22022576 TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. Wang CH et al. 2011 PloS one
22065095 TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. dos Santos BP et al. 2012 Lupus
22414065 Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. Arav-Boger R et al. 2012 BMC research notes
22857391 Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study. Nilsson D et al. 2012 BMC medical genetics
23227085 Genetics of SLE: functional relevance for monocytes/macrophages in disease. Byrne JC et al. 2012 Clinical & developmental immunology
23776356 Allergic rhinitis and genetic components: focus on Toll-like receptors (TLRs) gene polymorphism. Gao Z et al. 2010 The application of clinical genetics
24176007 Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population. Yang Y et al. 2013 BMC infectious diseases
24281113 Inflammatory genetic markers of prostate cancer risk. Tindall EA et al. 2010 Cancers
24532514 Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China. Wei XS et al. 2014 Yonsei medical journal
24653663 Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations. J de AS et al. 2014 Current genomics
25560985 Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Skevaki C et al. 2015 Clinical and experimental immunology
25633712 Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma. Sabado RL et al. 2015 Cancer immunology research
26556041 TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study. Piaserico S et al. 2015 Pharmacogenomics
26680101 Genotypic distribution of common variants of endosomal toll like receptors in healthy Spanish women. A comparative study with other populations. Martínez-Robles E et al. 2016 Gene
26741133 Gene Polymorphism of Toll-Like Receptors and Lung Function at Five to Seven Years of Age after Infant Bronchiolitis. Lauhkonen E et al. 2016 PloS one
26762473 Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lee YH et al. 2016 Lupus
26784926 Molecular Determinants of GS-9620-Dependent TLR7 Activation. Rebbapragada I et al. 2016 PloS one
27498757 Post-bronchiolitis wheezing is associated with toll-like receptor 9 rs187084 gene polymorphism. Nuolivirta K et al. 2016 Scientific reports
28046022 Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children. Studzińska M et al. 2017 PloS one
28062211 Endosomal toll-like receptor gene polymorphisms and susceptibility to HIV and HCV co-infection - Differential influence in individuals with distinct ethnic background. Valverde-Villegas JM et al. 2017 Human immunology
28592890 Polymorphism in the gene encoding toll-like receptor 10 may be associated with asthma after bronchiolitis. Törmänen S et al. 2017 Scientific reports
28752959 Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. Fakhir FZ et al. 2018 Liver international
29267374 Association of toll-like receptors polymorphism and intrauterine transmission of cytomegalovirus. Eldar-Yedidia Y et al. 2017 PloS one
29947302 The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection. El-Bendary M et al. 2018 British journal of biomedical science
29964062 TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands. Buschow SI et al. 2018 Antiviral research
30321082 Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV. Mosaad YM et al. 2019 Immunological investigations
30793925 Polymorphisms in Toll-Like Receptors (TLRs)-7 and 9 Genes in Indian Population with Progressive and Nonprogressive HIV-1 Infection. Shaikh N et al. 2019 AIDS research and human retroviruses
31481269 Contribution of Toll like receptor polymorphisms to dengue susceptibility and clinical outcome among eastern Indian patients. Mukherjee S et al. 2019 Immunobiology
32450795 Genetic variation in toll like receptors 2, 7, 9 and interleukin-6 is associated with cytomegalovirus infection in late pregnancy. Mhandire DZ et al. 2020 BMC medical genetics
32554924 TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women. Azar P et al. 2020 JCI insight
32565728 TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ART. Singh H et al. 2020 Mediators of inflammation
33138336 Association of Genetic Polymorphisms in TLR3, TLR4, TLR7, and TLR8 with the Clinical Forms of Dengue in Patients from Veracruz, Mexico. Posadas-Mondragón A et al. 2020 Viruses
33350746 Association of toll-like receptor polymorphisms with acquisition of HIV infection and clinical findings: A protocol for systematic review and meta-analysis. Shi H et al. 2020 Medicine
33495940 Differential genotypic signatures of Toll-like receptor polymorphisms among dengue-chikungunya mono- and co-infected Eastern Indian patients. Sengupta S et al. 2021 European journal of clinical microbiology & infectious diseases
34102513 Impact of TLR7 and TLR9 polymorphisms on susceptibility to placental infections and pregnancy complications. Sánchez-Luquez K et al. 2021 Journal of reproductive immunology
34113509 Study of Single Nucleotide Polymorphisms in Endosomal Toll-Like Receptors-3, 7, and 9 Genes in Patients With Dengue: A Case-Control Study. Singh AK et al. 2021 Cureus
34512664 Sex Differences in Primary HIV Infection: Revisiting the Role of TLR7-Driven Type 1 IFN Production by Plasmacytoid Dendritic Cells in Women. Guéry JC et al. 2021 Frontiers in immunology
34740476 TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine. Miya TV et al. 2021 Vaccine
35063671 Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study. Alseoudy MM et al. 2022 Clinical immunology (Orlando, Fla.)
35327350 The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes. Minashkin MM et al. 2022 Biomedicines
36016941 Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study. Bodro M et al. 2022 Frontiers in immunology
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d